Israel to Produce 15 Million Doses of Its COVID-19 Vaccine, Research Institute Says

The third and final phase of testing on Israel's single-dose vaccine is expected to begin in April, says the director of the Institute for Biological Research

Send in e-mailSend in e-mail
Israeli test participant in coronavirus vaccine trial, in  November.
Israeli test participant in coronavirus vaccine trial, in November.Credit: Oren Ben-Hakun

Comments